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Abstract
Despite the availability of the human papillomavirus (HPV) vaccine, African American
women are still at risk for contracting HPV. This is significant because HPV is one of
the main risk factors for cervical cancer. The purpose of this quantitative study was to
explore the relationship between the use of HPV vaccination for cervical cancer
prevention and personal history of HPV, reduced access to healthcare, and risky sexual
behaviors in African American women. The theoretical framework used for this study
was the health belief model (HBM). Two hundred twenty-nine (n=229) African
American women living in the United States, ages 18-49, who participated in the 20132014 National Health and Nutrition Examination Survey (NHANES) were the sample
under study. A univariate analysis was performed to describe the population and obtain
frequencies and percentages for all covariates. A bivariate analysis was conducted to
determine whether there was an association between any of the independent variables and
the dependent variable. A multivariable logistic regression was conducted to build a
predictor model for use of HPV vaccination. Women between the ages of 18 and 34
were 7.22 times as likely to receive the HPV vaccine as women aged 35-49 years, and
this was statistically significant (OR: 7.22; 95% CI: 2.36 – 22.13). This study can
contribute to positive social change within the community and public health profession
through an increased awareness and knowledge of HPV and cervical cancer, especially
for African American women.
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Dedication
Being black in this world certainly comes with its struggles, but I would not trade
that integral part of my identity for anything! #BlackGirlMagic is real and has been
since the beginning of time! It is however a sad element that we are often plagued with
disproportionately high incidences and mortality rates for heart disease, breast and
cervical cancer, sickle cell, fibroids, premature births, STIs/STDs, mental health issues
and so much more. It sounds scary because we feel like we are always the target, but
knowledge is power and for that...this work is dedicated to you! For our journeys in
learning to educate ourselves, our communities, and being an advocate for our own
health equity, health quality, and health disparities is one that will raise alarm and
awareness. After all…
“All knowledge meets an end at the question...Why?” ―Criss Jami, Healology
Too often we are seen as ‘running but never catching up’ and handed few choices
and even fewer protections. But, we must remember that we are strong, worthy, resilient,
and the greatest gift to mankind. Thus, our very existence and health is the upmost
importance because if we don’t take it seriously, who will? I hope this work inspires you
and contributes to your insightfulness and exploration of health issues affecting us black
women. After all…
“We do not know a truth without knowing its cause.” ―Aristotle, Nicomacheian
Ethics, I.1.

I have spent my entire academic journey on trying to figure out how I as a public
health practitioner and researcher can educate and improve health statuses and quality of
life for black and minority women. A wise man once said we cannot be informed if the
information is not better. So, here’s to learning, educating, and changing headlines.
After all…
“I have never felt more confident in myself, more clear on who I am as a
woman…But I am constantly thinking about my own health.” —Michelle Obama
Last but certainly not least, this humble work is dedicated to and is a sign of my
love for all of the strong black men and women leaders and role models in my family,
circle of networks, and other political, social, philanthropic, and health fields that have
demonstrated conviction and shown me what it means to be truly authentic. A special
heartfelt thank you to those family members, friends, and Sorors of Alpha Kappa Alpha
Sorority, Incorporated who have seen my potential, called it out, and began addressing
me as “Dr. Dee”, “Dr. Hanson”, “Dr. Diamond”, or “Dr. Bestie” long before I was given
this title. I love you all and I am forever grateful of the unconditional love, support,
enthusiasm, and encouragement you all have given me! And to the leaders who are yet to
come but are experiencing the moments that matter, I see you Kings and Queens…keep
smiling, stay focused, and don’t ever let anyone dim your light!
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Section 1: Foundation of the Study and Literature Review
Introduction
The human papillomavirus (HPV) is the most common sexually transmitted
infection (STI) in the United States (Vázquez-Otero et al., 2016; Young et al., 2015).
HPV is so common that the Centers for Disease Control and Prevention (CDC) stated that
almost every sexually active person will become infected with HPV at some point in their
lifetime (CDC, 2017a). There are two main types of HPV: low-risk (LR-HPV) and highrisk (HR-HPV). LR-HPV causes approximately 90% of genital warts and HR-HPV,
especially HPV-16 and 18, causes more than 70% of cervical cancer cases (CDC, 2017a;
Winer et al., 2006). Furthermore, the CDC estimated that each year, HPV will cause
cancer in 17,000 women (CDC, 2017a). These statistics reveal a public health issue that
is more alarming for certain racial/ethnic groups. Previous researchers have presented
varying results which have found that African American women who were screened as
much or at higher rates than Caucasian women still exhibited the highest cervical cancer
mortality rate (King, Chen, Garza, & Thomas, 2014; Downs Jr., Scarinci, Einstein,
Collins, & Flowers, 2010).
This study contributes to positive social change within the community and the
public health profession. Individuals and communities will have an increased awareness
and knowledge about HPV, cervical cancer, the relationship between the two, and the
importance of receiving the HPV vaccine. As a result, the dissemination of this
information by public health practitioners would aid in increased vaccination rates,
decreased HPV infections, and decreased cervical cancer diagnoses and fatalities,
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especially among African American women. This study is unique because it explores the
relationships between the use of HPV vaccination and personal history of HPV, reduced
access to healthcare, and sexual behaviors among African American women, ages 18–49,
in the United States, whereas previous studies have explored this relationship in specific
geographical locations.
In Section 1, I present the problem statement and purpose of the study. Following
these subsections, I discuss the studies’ research questions and hypotheses, as well as the
theoretical foundation and nature of the study. Next, I present a detailed literature search
strategy and an extensive literature review, including definitions (see Appendix A for
more information on abbreviations), assumptions, scope, and delimitations. Lastly, I
explore the significance of the study and potential contributions to the areas of policy
and/or practice and a summary of the literature.
Problem Statement
HPV is the most commonly STI in the United States with approximately 79
million Americans currently infected, and 14 million new infections occurring each year
(Vázquez-Otero et al., 2016; Young et al., 2015). Half of these infections occur among
individuals between the ages of 15 and 24. Despite the availability of the HPV vaccine,
African American women in the United States, ages 18–49, are still at risk for contracting
HPV, which causes cancer.
To date, many studies have been conducted on HPV vaccinations and Pap smear
screenings and the disparities that exist among African American women compared to
other racial/ethnic groups. Although African American women are just as likely or more
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than likely to have a Pap smear than Caucasian women, they are more likely to die from
the disease than Caucasian women (Brown, Wilson, Boothe, & Harris, 2011). Studies
suggest that African American women are less likely to be educated about the risk of
HPV and its relationship to cervical cancer compared to women of other racial/ethnic
groups due to personal history of HPV, reduced access to healthcare, and risky sexual
behaviors, which can all influence HPV infections (Mullins et al., 2016; Vázquez-Otero
et al., 2016; Strohl et al., 2015; Okafor, Hu, & Cook, 2015;Mayhew et al., 2014; Laz,
Rahman, & Berenson, 2012; Wong & Do, 2012; Brown, Wilson, Boothe, & Harris, 2011;
Dempsey, Cohn, Dalton, & Ruffin, 2011; Downs, Scarinci, Einstein, Collins & Flowers,
2010; Garner, 2003). More recently, new research has suggested that African American
women are infected with strains of cervical cancer-causing HPV subtypes (i.e. 31, 35, 45,
56, 58, 66 and 68) that the current vaccines do not protect against, which may
significantly contribute to higher cervical cancer morbidity and mortality rates (Vidal et
al., 2014).
Purpose of the Study
The purpose of this quantitative study was to explore the relationship between the
use of HPV vaccination and personal history of HPV, reduced access to healthcare, and
risky sexual behaviors among African American women, ages 18–49, in the United
States. The identified independent variables were personal history of HPV, reduced
access to healthcare, and sexual behavior. The dependent variable was the use of HPV
vaccination. Covariates included in this study were age, marital status, annual household
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income, educational attainment, and specific risky sexual behaviors. For the purposes of
this study, ‘use’ and ‘receipt’ of HPV were used interchangeably.
Research Questions and Hypotheses
The following were the research questions and associated hypotheses for this
study:
Research Question 1 (RQ1): Is there an association between use of HPV
vaccination and personal history of HPV among African American women, ages 18–49?
Null Hypothesis (H01): There is no association between use of HPV vaccination
and personal history of HPV among African American women, ages 18–49.
Alternative Hypothesis (Ha1): There is an association between use of HPV
vaccination and personal history of HPV among African American women, ages 18–49.


Dependent Variable: Use of HPV vaccination for cervical cancer prevention



Independent Variable: Personal history of HPV

Research Question 2 (RQ2): Is there an association between use of HPV vaccination
and reduced access to healthcare among African American women, ages 18–49?
Null Hypothesis (H02): There is no association between use of HPV vaccination
and reduced access to healthcare among African American women, ages 18–49.
Alternative Hypothesis (Ha2): There is an association between use of HPV
vaccination and reduced access to healthcare among African American women, ages 18–
49.


Dependent Variable: Use of HPV vaccination for cervical cancer prevention



Independent Variable: Reduced access to healthcare
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Research Question 3 (RQ3): Is there an association between use of HPV vaccination
and risky sexual behaviors among African American women, ages 18–49?
Null Hypothesis (H03): There is no association between use of HPV vaccination
and risky sexual behaviors among African American women, ages 18–49.
Alternative Hypothesis (Ha3): There is an association between use of HPV
vaccination and risky sexual behaviors among African American women, ages 18–49.


Dependent Variable: Use of HPV vaccination for cervical cancer prevention



Independent Variable: Risky sexual behaviors
Theoretical Foundation for the Study
The theoretical framework for this study was based on the health belief model

(HBM), which is shown in Figures 1 (health belief model components) and 2 (health
belief model for HPV vaccination). Developed in the 1950s by social psychologists,
Hochbaum, Rosenstock, and Kegels, who worked for the United States Public Health
Services, the HBM is a psychological model that attempts to describe and predict health
behaviors (Glanz, Rimer, & Lewis, 2002; Rosenstock, 1974). By focusing on the
attitudes and beliefs of individuals, the HBM was developed in response to the failure of
a free tuberculosis health screening program. Since its inception, the HBM has been
adapted to explore various long and short-term health behaviors, and most notably, risky
sexual behaviors and the transmission of HIV/AIDS and other STIs (Glanz, Rimer, &
Lewis, 2002; Rosenstock, 1974). Per Conner and Norman (1996), the HBM has been
applied to a broad range of health behaviors such as “preventive health behaviors, which
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include health-promoting (e.g. diet, exercise) and health-risk (e.g. smoking) behaviors as
well as vaccination and contraceptive practices.”
To date, the HBM has been used by a plethora of studies surrounding HPV and
cervical cancer, the factors and beliefs that contribute to HPV infection, and the issues
surrounding cervical cancer prevention (i.e. HPV vaccine, Pap smear screening and
follow-up) (Brown, Wilson, Boothe & Harris, 2011; Bynum et al., 2011; Hsu et al., 2009;
Rosenthal et al., 2010). Research has suggested that health beliefs can influence whether
an individual will accept and undergo HPV vaccination (Bynum et al., 2011; Rosenthal et
al., 2010; Hsu et al., 2009). Furthermore, Rosenstock (1974) believed that participation
in preventive health behaviors depends on an individual’s perceived susceptibility to
disease (HPV), severity of health outcomes (cervical cancer morbidity and/or mortality),
benefits of and barriers (personal history and reduced access to healthcare) to behavior
engagement, and cues to motivate action (conversations with healthcare providers, an
increased knowledge about HPV and cervical cancer, and vaccination for cervical cancer
prevention). The HBM provides a useful framework for creating prevention and
intervention programs, which would help improve HPV and cervical cancer knowledge,
and vaccination initiation and completion rates among African American women (Brown,
Wilson, Boothe & Harris, 2011). For the purposes of this study, the core assumption is
that an individual will take a health-related action (i.e. utilize condoms, participate in
HPV vaccinations, and become more knowledgeable about HPV and cervical cancer) if
that individual:
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1. Feels that a negative health condition/disease/infection, such as HPV, can be
avoided.
2. Has a positive expectation that by taking a recommended action, she will
avoid a negative health condition (i.e. utilizing safe sex practices to avoid
HPV infection, and receiving the HPV vaccination to protect against cervical
cancer),
3. Believes she can successfully take a recommended health action (i.e. utilizing
safe sex practices comfortably, speaking openly with healthcare providers and
parents with children, etc.)

Health Belief Model Components
Perceived
Perceived Benefits Perceived
Perceived
Modifying
Cues to Action
Susceptibility • An individual's
Barriers
Seriousness
Variables
• Those factors
• An invidual's
conclusion as to • An
• An
• An
that will start
assessment of whether the new
individual's
individual's
individual's
a person on
his or her
behvior /outcome opinion as to
judgement as
personal
the way to
chances of
is better than
what will stop to the severity factors that
changing
getting a
what he or she is
him or her
of the
affect whether behavior(s).
disease/condit already doing or
from adopting disease/condit the new
ion.
not doing.
the new
ion.
behavior(s) is
behavior(s).
adopted.

Figure 1. Health belief model components.

Self-Efficacy
• Personal
belief in one's
own ability to
do something.
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Figure 2. Health belief model for HPV vaccination for cervical cancer prevention.
Adapted from" Factors influencing medication adherence and hypertension management
revisited: recent insights from cancer survivors," by M. Morgado and S. Rolo, 2012,
Hypertension Research, 35(9), p. 894-896.
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Nature of the Study
The nature of this study was a quantitative, cross-sectional study design. This
allows an observation of data collected at a specific point in time (2013–2014) in order to
assess the prevalence of HPV vaccination use. The identified independent variables were
personal history of HPV, reduced access to healthcare, and risky sexual behaviors. The
dependent variable was use of HPV vaccination for cervical cancer prevention. Age,
marital status, annual household income, educational attainment, and specific risky
sexual behaviors were the identified covariates.
Secondary analysis of the National Health and Nutrition Examination Survey
(NHANES) archived data were utilized for this study. NHANES is a recurring,
population-based survey that was designed to assess the health and nutritional status of
adults and children in the United States (CDC, 2017c). The NHANES interview includes
information on demographics, socioeconomic factors, dietary behaviors, and healthrelated questions. I used demographic, laboratory, and health-related questionnaire data
files from 2013–2014, as these years provided the most recent data for the variables. The
study population was African American women between the ages of 18 and 49. I
performed a univariate analysis to describe the population and obtain frequencies and
percentages for all study variables. I also conducted a bivariate analysis to determine
whether there was an association between any of the independent variables and the
dependent variable. As a result of the bivariate analysis, the independent variables to be
included in the multivariable logistic regression, which is conducted to build a predictor
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model for use of HPV vaccination, were identified. Adjusted odds ratio (OR) and 95%
CIs were generated and significant p-values were reported as p < .05.
Literature Search Strategy
The following literature review includes my summary of the prevailing research
on the use of HPV vaccination and personal history of HPV, reduced access to
healthcare, and risky sexual behaviors of African American women in the United States,
ages 18–49. Relevant literature was obtained by using multiple search engines and
databases, including Google Scholar, PubMed, Google Scholar, MedlinePlus, and the
Walden University Library system. Additional data and information were collected
online from the CDC and the American Cancer Society (ACS).
The key terms and combinations of search terms I used for the literature review
included the following: HPV and African American women, cervical cancer and African
American women, HPV vaccination knowledge/attitudes/beliefs among African American
women, HPV vaccination, black women and HPV, black women and cervical cancer,
HPV vaccine and healthcare providers/physicians, HPV vaccine uptake among African
American women, HPV racial/ethnic disparities, barriers to HPV vaccination, and HPV
and risky sexual behaviors among African American women. I ensured the most current
literature was used by limiting the search to the years 2010 to 2016.
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Literature Review Related to Key Variables and/or Concepts
Personal History of HPV
Use of HPV vaccination and overall knowledge and education about HPV,
cervical cancer, and the relationship between the two can heavily influence the risk of
HPV infection, which can then lead to cervical cancer incidence and/or mortality.
Racial/ethnic disparities are prevalent with respect to cervical cancer screening,
incidence, and mortality. For instance, rates of cervical cancer incidence per 100,000
people for African American women is 9.8 per compared to 7.0 for Caucasian women,
9.9 for Hispanic women, 9.7 for American Indian and Alaska native women, and, 6.1 for
Asian and Pacific Islander women (ACS, 2017a). Cervical cancer mortality rates per
100,000 people for African American women is 3.9 compared to 2.1 for Caucasian
women, 2.6 for Hispanic women, 2.8 for American Indian and Alaska native, and 1.7 for
Asian and Pacific Islander women (ACS, 2017a). Downs Jr., Scarinci, Einstein, Collins,
and Flowers (2010) found that although African American women were screened at
higher rates (88% received at least one Pap smear between 2003 and 2006) than
Caucasian women, they still exhibited the highest cervical cancer mortality rate
(4.7/100,000) and the second highest incidence rate (10.8/100,000) (Downs Jr., Scarinci,
Einstein, Collins, & Flowers, 2010). The authors suggested that this may be due to poor
adherence to post-screening follow-up recommendations and dissimilar management of
abnormal cytology, cervical dysplasia, and cervical cancer in African American women
despite this group being more likely to complete timely screenings than Caucasian
women (King, Chen, Garza, & Thomas, 2014).
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In 2015, Strohl et al. sought to study the knowledge of HPV, cervical cancer, and
HPV vaccination in African American women living in urban Chicago. Using a
quantitative cross-sectional design, 322 surveys were distributed to African American
women ages 18-70. These surveys assessed knowledge of HPV, cervical cancer, and the
HPV vaccine. Two hundred and forty-two surveys were collected and 215 of the
subjects met inclusion criteria. The average knowledge score was 12.3 ± 4.2 (mean ±
SD) out of a maximum score of 28 (range, 3–23) in which 73% of participants scored
<65% on the knowledge section of the survey, while educational level (P= .007),
household income (P=.010) and having a child who had been offered the HPV vaccine
(P=.041) were associated with adequate (65% accuracy) knowledge scores (Strohl et al.,
2015). The authors concluded that knowledge of HPV, cervical cancer, and HPV
vaccination was low in this urban African American adult female population and that
specific educational health programs are needed to increase awareness among this
population. Furthermore, findings from this study were consistent with previous results
in similar studies that found that African American women were more likely to have less
knowledge of HPV, cervical cancer, and HPV vaccination. This study, however, was
limited as it recruited urban women through convenience sampling. Because this sample
was not random, it might not have been representative of all African American women.
Okafor, Hu, and Cook (2015) sought to determine whether there is a relationship
between racial/ethnic status and the initiation and completion of the HPV vaccine in
college women between the ages of 18 and 26 years of age recruited from a large college.
The women completed surveys that gathered information on sociodemographic

13
characteristics, risky sexual behaviors, gynecological healthcare use, and perception of
risk of acquiring HPV-associated diseases” (Okafor, Hu, & Cook, 2015). A total of 53%
of the women indicated that they had at least one of the three doses of HPV vaccine, and
among them 70% stated they had completed the full vaccination series of three doses
(Okafor, Hu, & Cook, 2015). Black women were significantly less likely to report both
initiation and completion of the vaccine series than women of other racial/ethnic groups
(Okafor, Hu, & Cook, 2015). This study was one of the few that investigated
racial/ethnic differences in HPV vaccine uptake in college women, and it provided a 5year update on rates of initiation and completion of the HPV vaccine series (Okafor, Hu,
& Cook, 2015). However, this study was limited as the primary outcome was selfreported, which has potential for reporting bias in the estimates of HPV vaccine uptake
(Okafor, Hu, & Cook, 2015). In addition, other factors, such as socioeconomic status and
cultural health beliefs, which could have influenced the propensity to become vaccinated,
were not considered.
Laz, Rahman and Berenson (2012) conducted a study to provide an update on
HPV vaccine initiation among women between the ages of 18 and 26. Data from the
National Health Interview Survey were used to estimate HPV vaccine coverage and HPV
vaccine awareness, receipt of the vaccine, number of doses, perceived barriers, and
relevant socio-demographic variables. The survey focused on questions related to HPV
vaccine awareness, receipt of the vaccine, number of doses received, perceived barriers,
and relevant sociodemographic variables. The results showed that 77.3% of women ages
18-26 were not vaccinated. Out of those women, 68.6% were either not interested in
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receiving the vaccine or were unsure about receiving the vaccine due to the following
reasons: felt the vaccine was not needed (39.6%), insufficient knowledge about the
vaccine (12.7%), concerns about the safety of the vaccine (12.0%), vaccine was not
recommended by the physician (7.2%), was not sexually active (6.7%), and thought she
was too old for the vaccine (3.1%) (Laz, Rahman & Berenson, 2012). Racial/ethnic
disparities were present as black women were less likely to complete the series of three
doses of HPV vaccine than Caucasian women (Laz, Rahman & Berenson, 2012).
Furthermore, women who were uninsured were less likely to receive ≥1 dose (Laz,
Rahman & Berenson, 2012). The study had some limitations. First, the data
questionnaires were self-reported and may be subject to recall bias due to participants
giving desirable instead of truthful answers, personal feelings during the time,
embarrassment, and, questions being misread or misinterpreted. Next, information on
vaccine receipt and number of doses received was not confirmed by provider
immunization records, so there could have been some misclassification (Laz, Rahman &
Berenson, 2012). Also, this study did not assess risky sexual behaviors, making it
impossible to examine the association between risky sexual behaviors and receipt of
vaccine (Laz, Rahman & Berenson, 2012). In all, this study contributed to a better
understanding of racial/ethnic disparities, particularly among African American women,
as well as additional barriers to initiation and/or completion of the HPV vaccination
series.
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Reduced Access to Healthcare
Studies have shown that barriers to HPV vaccination include low socioeconomic
status as measured by income, low educational attainment, lack of insurance, and lack of
communication between healthcare providers and patients (Strohl et al., 2015; Wong &
Do, 2012; Dempsey, Cohn, Dalton, & Ruffin, 2011;Downs, Scarinci, Einstein, Collins &
Flowers, 2010; Garner, 2003).
Wong and Do (2012) used the 2007 Health Information National Trends Survey
(HINTS) to examine predictors of physician/patient discussion regarding the HPV
vaccine in women 18 and older. The survey asked the following question: “Has a
healthcare provider such as a doctor or nurse ever talked to you about a cervical cancer
vaccine or HPV shot?” Only women who reported ever having heard of the cervical
cancer vaccine or HPV shot before participating in the survey were asked this question
(Wong & Do, 2012). African American women were the highest percentage (26.6%) of
individuals who had HPV vaccine discussions wither their healthcare providers,
compared to Hispanic women (17.2%) and Caucasian women (15.8%) (Wong & Do,
2012). However, Caucasian women were the most likely (88.7%) to be aware of the
HPV vaccine, compared to African American women (73.2%) and Hispanic women
(58.8%) (Wong & Do, 2012). Furthermore, a statistically significant association was
observed between lower income and education levels and a lower likelihood of HPV
vaccine awareness (Wong & Do, 2012). However, low levels of income and education
did not affect the likelihood of having discussions about the HPV vaccine with healthcare
providers (Wong & Do, 2012).

A major limitation of this study was the short time
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interval between the FDA approval of the quadrivalent vaccine in 2006 and the launch of
the study in early 2008 (Wong & Do, 2012). Thus, the small number of respondents who
reported having the HPV vaccine discussions with their healthcare providers may not be
reflective of the corresponding situation today (Wong & Do, 2012).
Brown, Wilson, Boothe, and Harris (2011) studied the knowledge, attitudes,
beliefs, and practices of ethnically diverse black women in regard to cervical cancer
screening. Haitian, African, English-speaking Caribbean, and African American women
were recruited from a federally qualified health center. Focus groups were conducted to
discuss knowledge of and preventive measures against cervical cancer and HPV,
facilitators of cervical cancer screening, and barriers to cervical cancer screening (Brown,
Wilson, Boothe, & Harris, 2011). Reduced access to healthcare was discussed as it
relates specifically to the barriers to cervical cancer screening among these groups of
women. First, in studies of cervical cancer screening among black women, frequent
change of residence which would necessitate a change in healthcare provider and lack of
regular source of care, inability to take time off of work, lack of trust towards physicians,
high cost of screening and treatment, family financial obligations, transportation costs,
language, and citizenship status were major barriers to cervical cancer screening (Bigby,
Ko, Johnson, David, & Ferrer, 2003; Brown, Wilson, Boothe, & Harris, 2011; Gany,
Herrera, Avallone, & Changrani, 2006; Ponce et al., 2006; Tsui, Saraiya, Thompson,
Dey, & Richardson, 2007). A major limitation of this study was the limited
generalizability due to the small sample of 44 primarily low-income black women. Due
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to this small sample, authors suggested that there is a great need to further explore the
health-seeking behaviors of this population.
Dempsey, Cohn, Dalton, and Ruffin (2011) evaluated characteristics associated
with HPV vaccine uptake among women between the ages of 19 and 26 seen in primary
care, university- based clinics. As an extension from a previous study, clinical visit data
(medical records and billing data) from the University of Michigan Health System were
utilized to retrospectively assess various factors associated with HPV vaccine use
(Dempsey, Cohn, Dalton, & Ruffin, 2011). Although there were 11,545 women, only
18% had initiated the three dose vaccine series (Dempsey, Cohn, Dalton, & Ruffin,
2011). There was reduced series initiation among older aged women, women who were
publicly insured and Caucasian women (Dempsey, Cohn, Dalton, & Ruffin, 2011). On
the other hand, there was a decrease in series completion among those who were publicly
insured and African American (Dempsey, Cohn, Dalton, & Ruffin, 2011). Furthermore,
results showed disparities by race and insurance worsened over time, which suggested
that high risk populations were not getting vaccinated (Dempsey, Cohn, Dalton, &
Ruffin, 2011). While the population studied was both economically and racially diverse,
results are based on only one university-based health system located in the State of
Michigan and may therefore not be generalizable to larger geographic locales (Dempsey,
Cohn, Dalton, & Ruffin, 2011). In addition, this sample included a very small number of
individuals without health insurance. Young adults have higher rates of being uninsured
compared to other ages, and as a result, high out-of-pocket costs of HPV vaccines would
possibly prevent many of these uninsured individuals from being vaccinated (Adams,
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Newacheck, Park, Brindis, & Irwin, 2007; Dempsey, Cohn, Dalton, & Ruffin, 2011;
Park, Paul Mulye, Adams, Brindis, & Irwin, 2006).
Downs Jr., Scarinci, Einstein, Collins, & Flowers (2010) studied populations of
women in the United States at high risk for cervical cancer and assessed known reasons
for the current outcome disparities (i.e. perceptions, attitudes, knowledge). The authors
also explained ways in which the barriers for HPV vaccination could be reduced and
strategies for cervical cancer prevention by way of vaccine acceptance and initiation
could be improved. The methods for this study were developed by an expert forum
conducted in 2008 by the Society of Gynecologic Oncologists. Epidemiological data
were prepared and discussed by 56 experts in cervical cancer. One of the main barriers
discussed was reduced access to healthcare for which five dimensions were described by
Penchansky and Thomas (1981), including availability (volume and type of services vs.
location of clientele); accommodation (the ease of obtaining appointments); affordability
(cost and perceived ability to pay for care); and acceptability (perceptions about practice
characteristics). When examining socioeconomic status and race among African
American and Caucasian women, the authors found that family income was the strongest
predictor of total healthcare access (Downs Jr., Scarinci, Einstein, Collins, & Flowers,
2010). There was also a significant interaction between occupation and race for total
healthcare access. This meant that an individual’s occupation significantly predicted
accessibility, median income by zip code predicted accommodation, and family income
significantly predicted affordability (Downs Jr., Scarinci, Einstein, Collins, & Flowers,
2010). Furthermore, it was noted that impoverished women access healthcare less
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frequently than mainstream populations. Therefore, women are utilizing urgent or
emergent care only, which limits their participation in preventive care such as cervical
cancer screening (Downs Jr., Scarinci, Einstein, Collins, & Flowers, 2010; Sambamoorthi
& McAlpine, 2003). Further discussion and implementation initiatives that focus on
HPV awareness, knowledge, and vaccination will help eliminate disparities in cervical
cancer incidence and mortality.
Risky sexual behaviors
Rates of STIs continue to increase among African American youth (Raiford, Seth,
& DiClemente, 2013). Genital HPV is one of the most common STIs in the United States
and has the highest rate of infection among college-aged women between the ages of 20
and 24 (Bynum et al., 2011). High risk sexual behaviors, including engaging in anal,
oral, and/or vaginal sex without the use of a condom, multiple sex partners, early age at
first coitus, and high number of lifetime sexual partners, may contribute to an increase in
HPV transmission in African American women (Downs Jr., Scarinci, Einstein, Collins, &
Flowers, 2010; Raiford, Seth, & DiClemente, 2013).

Alcohol and drug use, which can

lead to the engagement in risky sexual behaviors, has also been studied as a risk factor for
HPV (Bennett et al., 2009; Bynum et al., 2011). In addition, the issue of whether
receiving the HPV vaccine could lead to altered risk perceptions, resulting in the
engagement of risky sexual behaviors, has also been studied (Mayhew et al., 2014;
Mullins et al., 2016; Vázquez-Otero et al., 2016).
Vázquez-Otero et al. (2016) examined whether HPV vaccination was associated
with inconsistent condom use among college students between the ages of 18 and 26,
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using the National College Health Assessment-II dataset from fall 2013. HPV
vaccination was the primary predictor variable while risky sexual activity was the
outcome variable (Vázquez-Otero et al., 2016). There was no association between HPV
vaccination and inconsistent condom use in any sexual activities, including vaginal, anal,
or oral sex (Vázquez-Otero et al., 2016). These findings were consistent with previous
studies, which also found no differences in the number of sex partners and frequency of
condom use between individuals who were vaccinated and those who were not
(Ratanasiripong, 2014). Additionally, a study by Mayhew et al. (2014) found that there
were no changes observed in the initiation of sexual activity, number of sexual partners,
or condom use six months after receiving the HPV vaccine. One limitation of the study
by Vázquez-Otero et al. was that the data were self-reported which might have introduced
social-desirability (participants giving responses based on what they think the researcher
wants to hear) and non-differential misclassification biases (misinterpretation and/or false
answers).
In a similar study, Mullins et al. (2016) sought to examine the association
between risk perceptions after receiving the HPV vaccine and risky sexual behaviors and
STI diagnosis over 30 months following vaccination. Sexually experienced women
between the ages of 13 and 21 who had completed ≥2 of 4 follow-up visits at 2, 6, 18, 30
months and including 30 months were enrolled at the time of their first HPV vaccination
(Mullins et al., 2016). During each visit, participants were asked about their perceived
need for safer sexual behaviors and their perceived risk of STIs, other than HPV, as well
as their risky sexual behaviors (Mullins et al., 2016). During each visit participants

21
completed surveys that assessed risk perceptions (“perceived need for safer sexual
behaviors, perceived risk of STIs other than HPV”) and risky sexual behaviors (Mullins
et al., 2016). Condom use at last intercourse with main male partner, number of sexual
partners since last study visit, and STI diagnosis were outcomes. Scale scores indicated
that while perceived need for safer sexual behaviors did not change significantly over
time, scale scores for perceived risk of STIs other than HPV decreased over time
(p=0.027) (Mullins et al., 2016). Thus, after 30 months following the HPV vaccination,
girls perceived themselves to be more at risk of STIs other than HPV than previously
(Mullins et al., 2016). A multivariate model demonstrated that while the greater
perceived need for safer sexual behaviors following vaccination was associated with
condom use, it was not associated with the number of sexual partners or STI diagnosis
(Mullins et al., 2016). In addition, perceived risk of STIs other than HPV was not
associated with the three variables (Mullins et al., 2016). However, because there was no
available information about risk perceptions for participants prior to their receipt of the
first HPV vaccine dose, changes between pre-and post-vaccination risk perceptions could
not be examined (Mullin et al., 2016). The findings of this study suggested that the HPV
vaccination visit is a vital opportunity for health professionals to reiterate the importance
of safer sexual behaviors to those who are sexually active, and further, to those who are
not yet sexually active (Mullins et al., 2016).
Mayhew et al. (2014) assessed whether adolescent risk perceptions after the first
vaccine dose predicted subsequent risky sexual behaviors. Questionnaires were
completed after receiving the HPV vaccination and then two and six months later by girls
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between the ages of 13 and 21. Participants were assessed based on their demographic
characteristics, knowledge/attitudes about the HPV vaccine, risk perceptions, and risky
sexual behaviors. For the 42.5% of girls who were sexually inexperienced, risk
perceptions at baseline were not associated with subsequent sexual initiation (Mayhew et
al., 2014). Girls 16 to 21 who reported lower perceived risk of STI were less likely to
initiate sex (Mayhew, 2014). In addition, among all sexually active participants, baseline
risk perceptions were not associated with subsequent number of sexual partners or
condom use (Mayhew, 2014). Finally, risk perceptions after HPV vaccination were not
associated with riskier sexual behaviors over the subsequent six months of the study
(Mayhew, 2014). This study is significant in contributing to the growing evidence that
receiving the HPV vaccine does not alter risky sexual behaviors among adolescents
(Mayhew, 2014). This study was limited as it was conducted within a population
comprised mainly of low-income black women, which could limit generalizability. The
current study will look at African American women from all socioeconomic
backgrounds.
Literature Summary
Literature focusing on personal history of HPV, reduced access to healthcare, and
risky sexual behaviors, which can all impact the use of HPV vaccination among African
American women, has been discussed. Okafor, Hu, and Cook (2015), Laz, Rahman and
Berenson (2012), and Strohl et al., (2015) presented similar findings and concluded that
knowledge about HPV and cervical cancer and HPV vaccine initiation and completion
can influence the risk of HPV infection, which can lead to cervical cancer. The studies
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conducted by Brown, Wilson, Boothe and Harris (2011), Dempsey, Cohn, Dalton and
Ruffin (2011), Downs Jr., Scarinci, Einstein, Collins and Flowers (2010), and Wong &
Do (2012) and explained that barriers to the utilization of the HPV vaccine include
limited access to healthcare, low socioeconomic status, low educational attainment, and,
lack of communication between providers and patients. Lastly, while engaging in risky
sexual behaviors can lead to HPV infection, studies by Mayhew et al. (2014), Mullins et
al. (2016), and Vázquez-Otero et al. (2016) concluded that a change in risky sexual
behaviors was not associated with vaccine initiation.
Definitions
Cancer: With over 100 types, cancer is the leading cause of death worldwide and
the second leading cause of death in the United States, causing approximately 8.2 million
deaths in 2012 (National Cancer Institute [NCI], 2014a; Siegel, Ma, Zou & Jemal, 2014;
Stewart & Wild, 2014). In 2017, the ACS predicts approximately 1.7 million new cancer
cases and over 600,000 deaths (ACS, 2017a). The International Agency for Research on
Cancer (IARC) predicted that by the year 2030 there will be 21.4 million new cancer
cases and 13.2 million cancer deaths globally (ACS, 2015). Furthermore, in 2017, the
ACS predicts 12,820 new cases of invasive cervical cancer, resulting in 4,210 deaths
(ACS, 2017a).
Cervical cancer: Cervical cancer is the third most commonly diagnosed cancer in
women worldwide (Arbyn et al., 2011; Ferlay et al., 2014). In 2012, there were an
estimated 528,000 new cases and 266,000 deaths worldwide (Ferlay et al., 2014).
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According to the National Institutes of Health (NIH), the United States ranks 14th in the
world for cervical cancer cases (NIH, 2013). In 2013, there were nearly 250,000
American women living with cervical cancer (NCI, 2015).
At the opening of the uterus into the vagina is an organ referred to as the cervix.
Cervical cancer is usually a slowly-developing disease that is initiated when cancerous
cells form in tissues of the cervix (NCI, 2014b). While cervical cancer can form in any
cervical cell, it primarily develops in those cells lining the surface of the cervix (NCI,
2014b), squamous and columnar cells (Chen, 2013). Squamous cell carcinomas account
for 80 to 90 percent of cervical cancers. Adenocarcinomas develop from columnar cells
and account for 10 to 12 percent of cervical cancers (Schuiling, & Likis, 2017). While
there are multiple risk factors for cervical cancer, HPV is known to be a necessary cause
(NCI, 2014b).
HPV: Derived from the papillomavirus family and consisting of over 200 strains,
40 of which are transmitted sexually, HPV infects human skin and moist membranes that
line organs, including the throat, mouth, anus, and cervix (Sushma, Vamsikrishna, Babu
& Mohanraj, 2014). Being infected with HPV can also lead to the development of head
and neck squamous cell carcinoma (HNSCC) (Tan et al., 2015). HPV is primarily spread
through skin-to-skin or mucosa-to-mucosa contact, including oral, vaginal, or anal sex
(Burd, 2003; Schiffman, Castle, Rodriguez & Wachholder, 2007).
In the early 1980s, a German virologist named Harold zur Hausen was the first to
discover an association between HPV infection and cervical cancer (Gomez & Santos,
2007; zur Hausen, 1994). Thereafter, HPV was recognized as a necessary cause of
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cervical cancer, causing 99% of cases worldwide (Colombo et al., 2012; Gomez &
Santos, 2007; Vu, Bui & Le, 2013).
Today, cervical cancer prevention is conducted using the Papanicolaou (Pap)
smear. Created by George Nicholas Papanicolaou, who was credited with explaining the
physiological and cytological features of the female reproductive system, the Pap smear
is a method of obtaining cervical epithelial cells (Tan & Tatsumura, 2015). A pathologist
then examines these cells to determine if precancerous or cancerous changes have
occurred within the cervix (Tan & Tatsumura, 2015). Evidence has shown that 99% of
cervical cancer deaths are preventable with the use of the Pap smear among regularly
screened women (DeMay, 2000). Due to the strong association between HPV and
cervical cancer, the ACS, the United States Preventive Services Task Force (USPSTF),
and the American Society for Colposcopy and Cervical Pathology updated their
recommendations for the early detection of precancerous lesions in the cervix to include
screening for (HR)-HPV (Saslow et al., 2012). The revised screening recommendations
(please see Appendices E and F for more information on USPSTF grades and suggestions
for practice and cervical cancer screening recommendations) included the use of cytology
and HR-HPV testing, follow-up (e.g., the management of screen positives and screening
intervals for screen negatives) of women after screening, the age at which to discontinue
screening, future considerations regarding HPV testing alone as a primary screening
approach, and screening strategies for women vaccinated against HPV 16 and 18
infections (Saslow et al., 2012).

26
While cervical cancer is highly preventable through screening, researchers have
observed racial/ethnic disparities that persist in cervical cancer screening and deaths. Per
the National Center for Health Statistics (NCHS), except for two years, African American
women have had the highest rates of Pap smear screenings from 1987-2010 (NCHS,
2013). In 2010, the Pap smear rate for African American women was almost 78%,
followed by Hispanic women (73.6%), American Indian/Alaska Native women (73.4%),
Caucasian women (72.8%), and finally Asian women (68.0%) (data for Native Hawaiian
or other Pacific Islander were not reported), despite epidemiological data showing that
African American women are more likely to have cervical cancer and die from it (NCHS,
2013; Brown, Wilson, Boothe, & Harris, 2011). On the other hand, the rate of HPV
vaccination is low in the African American community, and this largely accounts for
cervical cancer disparities (Strohl et al., 2015). Several studies have noted that little or no
access to healthcare, lack of awareness and education about HPV and cervical cancer,
and risky sexual behaviors also contribute to these disparities (Brown, Wilson, Boothe, &
Harris, 2011; Downs, Scarinci, Einstein, Collins, & Flowers, 2010; Gelman et al., 2013;
Scarinci, Litton, Garcés-Palacio, Partridge, & Castle, 2013; Strohl et al., 2015).
HPV vaccines. The burden of HPV-related diseases, recent scientific findings of
viral etiology of several anogenital cancer types, and the development of prophylactic
vaccines have presented an unprecedented opportunity for cervical cancer prevention on
a global level (see Appendix D for more information on 2018 recommended
immunizations). In addition to cervical cancer screening by use of the Pap smear, there
are currently three Federal and Drug Administration (FDA) approved prophylactic HPV
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vaccines: Gardasil (Human Papillomavirus Quadrivalent Vaccine Recombinant; Merck &
Co., Inc.; approved in 2006), Gardasil 9 (Human Papillomavirus 9-valent Vaccine
Recombinant; Merck & Co., Inc.; approved in 2014), and Cervarix (Human
Papillomavirus Bivalent Vaccine, Recombinant; GlaxoSmithKline Biologicals; approved
in 2009) (ACS, 2017b; FDA, 2017; National Cancer Institute [NCI], 2015; Saslow et al.,
2007). Gardasil protects against HPV types 6, 11, 16, and 18 (FDA, 2017). Gardasil 9
protects against HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58 (FDA, 2017). Lastly,
Cervarix protects against HPV types 16 and 18 (FDA, 2017). The goal of these
prophylactic vaccinations is to reduce the incidence of HPV-related genital disease,
including cervical, penile, vulvar, vaginal, and anal cancer, and precancerous lesions
(Saslow et al., 2007).
Assumptions
An assumption identified is that because this study utilized a population-based
dataset to obtain subjects, the external validity of the study is increased. Secondly, it is
assumed that the current available vaccines may not adequately protect African American
women from HPV and cervical cancer due to the strains of HPV found in African
American women (Vidal et al., 2014).
Scope and Delimitations
A quantitative, cross-sectional study design was utilized for this study. NHANES
data from 2013–2014, with the inclusion criteria limited to African American women
between the ages of 18 and 49, were chosen as it contains the most up-to-date
information reported on the variables to be studied. As of result of utilizing NHANES,
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which is a database for secondary data analysis, there were no primary data collections or
contact with the participants in the study. Variables utilized in this study were all
included in NHANES. Therefore, no other databases were utilized. Since NHANES is a
population-based database and only African American women were analyzed, results can
be generalizable to larger African American populations. However, this study was
limited to a quantitative, cross-sectional design and there were no control or comparison
groups.
Significance of the Study and Potential for Positive Social Change
The purpose of this study was to determine the relationship between use of HPV
vaccination and personal history of HPV, reduced access to healthcare, and risky sexual
behaviors, controlling for age, marital status, annual household income, and educational
attainment. This study is significant as it can provide an avenue to achieve the following
behavioral and research outcomes:
 Increased awareness and education about HPV, cervical cancer, and the
relationship between the two.
 Increased knowledge and awareness about the importance of receiving the
HPV vaccination.
 Increased rates of HPV vaccinations for cervical cancer prevention.
 Exploration of the HPV vaccine effectiveness in African American
women.
This study contributes to positive social change within the community and the public
health profession through the areas of research, policy, and practice. First, research will
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better help individuals and communities understand the HPV vaccination disparities that
exist among African American women as well as why the current vaccinations are not
necessarily protective in African American women. Next, based on the research findings,
policies and new vaccines can be created to ensure that the most effective and equitable
practices and education are being executed and relayed to African American women via
health professionals, physicians, pharmaceutical companies, etc. Lastly, more
interventions can be implemented to help with this very preventable disease, resulting in
a decrease in morbidity and/or mortality of HPV and cervical cancer among African
American women.
Summary and Conclusions
Section 1 intricately described personal history of HPV, reduced access to
healthcare, and risky sexual behaviors and the literature pertaining to African American
women. Additionally, the purpose of the study, the nature of the study, the research
questions and hypotheses, and a detailed literature review with emphasis on limitations,
delimitations and assumptions were provided. This section concluded with a description
of the positive social change impact of the study. The subsequent section, Section 2,
focuses primarily on the research design and rationale, methodology, and threats to
validity.
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Section 2: Research Design and Data Collection
Introduction
The purpose of this study was to determine the relationships between use of HPV
vaccination and personal history of HPV, reduced access to healthcare, and risky sexual
behaviors in African American women, ages 18–49. This section includes the research
design and rationale, methodology, and threats to validity.
Research Design and Rationale
The identified independent variables were personal history of HPV, reduced
access to healthcare, and risky sexual behaviors. The dependent variable was use of HPV
vaccination for cervical cancer prevention. The covariates of this study were age, marital
status, annual household income, and educational attainment, which were controlled for
using a logistic regression analysis. I utilized a quantitative, cross-sectional study design
using secondary NHANES data collected during 2013 and 2014 due to its cost and time
effectiveness, I used the data to assess the prevalence of HPV vaccination use and
selected characteristics of the identified target population previously mentioned.
Methodology
In this section I defined how the study was conducted. I also discussed the study
population, sampling and sampling procedures used to collect data as described in
secondary data materials, instrumentation and operationalization of constructs, threats to
validity, and ethical procedures.

31
Population
As shown in Appendix C, NHANES unweighted sample size included 10,175
girls and women of all age ranges. However, the target population for this study was
African American women between the ages of 18 and 49. As a result of this studies’
inclusion and exclusion criteria, the sample population was n=229.
Sampling and Sampling Procedures Used to Collect Data
According to the CDC (2013), data from NHANES are not acquired using a
simple random sample. Instead, data are collected using a “complex, multistage,
probability sampling design” that is used to choose participants that are representative of
the “civilian, non-institutionalized US population” (CDC, 2013, para. 3). This complex,
multistage probability sample excludes individuals who reside in nursing homes, are
members of the armed forces, are institutionalized, and United States nationals living
abroad (CDC, 2013). Furthermore, according to the CDC,
Sample selection for NHANES followed these stages, in order: 1. Selection of
primary sampling units (PSUs), which are counties or small groups of contiguous
counties. 2. Selection of segments within PSUs that constitute a block or group of
blocks containing a cluster of households. 3. Selection of specific households
within segments. 4. Selection of individuals within a household; see the
‘‘Household Interview’’ section for more information on sample person selection.
(2013, para. 3)
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I utilized NHANES’ public 2013–2014 datasets and questionnaires. Because
information pertaining to the access of NHANES datasets is made available for data users
and researchers throughout the world online, it was not necessary to request permission to
gain access to the data that I used. To obtain the data, I completed the following steps,
which is shown in Figure 3:

Identified and
Searched for
NHANES Data
through Desired
Search Engine
(Google)

Selected Desired
Time Frame
(2013–2014)

Selected Desired
Data
(Demographics,
Laboratory, and
Questionnaire)

Opened Data
Files and
Reviewed and
Explanations

Saved Excel
Files for Data
Merge into SPSS

Figure 3. Accessing NHANES data.
Inclusion and exclusion criteria. African American women between the ages of
18 and 49 are included in this study. Women who had a positive pregnancy test at the
time of exam were excluded from this study.
Sample size. From 2013–2014, a total of 14,332 persons were selected for 30
different NHANES survey locations (CDC, 2017c). Of these, 10,175 people completed
the interview and 96% (9,813) of these individuals were examined (CDC, 2017c). From
this, 229 African American women between the ages of 18 and 49 were used for this
study.
Justification for the effect size, alpha level, and power level. I chose the
minimum effect size to allow for best external validity since this study was a multistage,
probability sampling design. I chose an alpha level of .05 to reduce Type 1 error while
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the power level of .80 reduced Type 2 error, according to Creswell (2013). I added a
nonresponse/attrition factor of 10% to account for nonresponse/attrition of selected
women. The choice of these figures was made for better external validity and improved
outcomes from generalization of the study findings, according to Sullivan (2012). Also, I
conducted a post hoc power analysis to evaluate the achieved statistical power, please see
p. 41 of Section 3 for more details.
Instrumentation and Operationalization of Constructs
NHANES serves as a great tool for conducting research on the health and
nutrition of household populations in the United States (CDC, 2016). NHANES data has
been used to influence policy, create health programs and services, expand knowledge
about the health of people in the United States, and improve the health of the United
States population, such as removing lead from gasoline, establishing national baseline
estimates for cholesterol, blood pressure, and Hepatitis C, and creating and updating
pediatric growth charts (CDC, 2016). I utilized NHANES data for this study to explore
the many factors that influence use of HPV vaccination for cervical cancer prevention in
African American women.
Data have been collected by NHANES since 1959 in three separate time periods:
The National Health Examination Survey (NHES) era (1959–1970), the periodic and
population-specific NHANES era (1971–1994), and the continuous NHANES era from
1999 forward (Zipf, G., Chiappa, M., Porter, KS et al., 2013). Since 1999, the National
Center for Health Statistics has released public use data from the continuous NHANES in
two year cycles (Zipf, G., Chiappa, M., Porter, KS et al., 2013). As previously
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mentioned, I utilized data from 2013–2014. I also used three out of six available
datasets: demographics (population characteristics), laboratory (disease results), and
questionnaire (lifestyle behaviors) which all contained relevant variables for this study.
Operationalization. The independent variables for this study were personal
history of HPV, reduced access to healthcare, and risky sexual behaviors. I defined
personal history of HPV as ever being told by a doctor one had HPV. I defined reduced
access to healthcare by whether an individual was covered by health insurance (“yes” or
“no”), whether the person had a routine place to go for healthcare (“yes” or “no”), and the
number of times healthcare had been received over the past year (0, 1–3, and ≥4). Lastly,
I defined risky sexual behaviors as if one had ever engaged in sex without use of condom,
the number of sexual male partners, and coitarche – age at first sexual intercourse. My
dependent variable was use of HPV vaccination and was defined by whether an
individual had ever received a Gardasil or Cervarix HPV vaccination. This variable was
categorical (“yes” or “no”).
The covariates I used in this study were age, marital status, educational
attainment, and annual household income. I selected covariates based on statistical,
social, and biological relationships with HPV. Age was categorized into the following
groups: 18–34 and 35–49. Marital status was categorized as married, widowed, divorced,
separated, never married, or living with a partner. Educational attainment was
categorized as less than 9th grade, Grades 9–12, having attained a high school
diploma/GED or equivalent, having attended some college or attained an associate’s
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degree, and having completed college or above. Annual household income was
categorized as ≤$39,999, $40,000-$59,999, $60,000-$75,999, and ≥$80,000.
Data analysis plan. I analyzed data using the Statistical Package for Social
Sciences® (SPSS) version 21. The phases of the analysis are shown in Figure 4. I
validated data by using the SPSS Data Validation add-on module, which enabled users to
identify doubtful or unsound cases, variables, and data values, view patterns of missing
data, and summarize variable distributions, thus allowing users to determine data validity
and removing or correcting cases prior to analysis (SPSS, 2014). To ensure accurate and
effective data analyses, identified variables were recoded and manipulated in line with
the research questions and data operationalization plans. Descriptive statistics were
created and the results were used to create tables and charts. Univariate (simple
frequencies and percentages), bivariate (Pearson’s correlation coefficient, Chi-Square
analyses), and logistic regression analyses were performed to identify relationships,
measure levels of significance of associations between independent and dependent
variables, and to reduce statistical errors. Furthermore, p-values, adjusted odds ratios and
95% confidence intervals (CIs) were calculated. A summary of the statistical procedures
and the relevant questions and hypotheses is provided in Table 1.

Basic Descriptive
Analysis
(Frequencies and
Percentages)
Figure 4. Data analysis process.

Inferential
Analysis
(Chi-square,
Logistic
Regression, etc.)

Results/
Conclusions
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Table 1
Research Questions, Hypotheses, and Appropriate Statistical Procedures
Research Question

Hypothesis

Variables

Is there an association
between use of HPV
vaccination and personal
history of HPV among
African American women,
ages 18–49?

There is an association between
use of HPV vaccination and
personal history of HPV among
African American women, ages
18–49.

DV- HPV vaccination
use

Is there an association
between use of HPV
vaccination and reduced
access to healthcare among
African American women,
ages 18–49?

There is an association between
use of HPV vaccination and
reduced access to healthcare
among African American
women, ages 18–49.

Is there an association
between use of HPV
vaccination and risky sexual
behaviors among African
American women, ages 18–
49?

There is an association between
use of HPV vaccination and
risky sexual behaviors among
African American women, ages
18–49.

Statistical Procedure
Bivariate chi-square
analysis and logistic
regression

IV- Personal history of
HPV

DV- HPV vaccination
use

Bivariate chi-square
analysis and logistic
regression

IV- Reduced access to
healthcare
DV- HPV vaccination
use

IV- Risky sexual
behaviors

Bivariate chi-square
analysis and logistic
regression
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Research Questions and Hypothesis
I sought to explore the use of the HPV vaccination for cervical cancer prevention
in African American women. The research questions and hypotheses were as follows:
RQ1: Is there an association between use of HPV vaccination and personal history
of HPV among African American women, ages 18–49?
H01: There is no association between use of HPV vaccination and personal history
of HPV among African American women, ages 18–49.
H01: There is an association between use of HPV vaccination and personal history
of HPV among African American women, ages 18–49.
RQ2: Is there an association between use of HPV vaccination and reduced access to
healthcare among African American women, ages 18–49?
H02: There is no association between use of HPV vaccination and reduced access
to healthcare among African American women, ages 18–49.
H02: There is an association between use of HPV vaccination and reduced access
to healthcare among African American women, ages 18–49.
RQ3: Is there an association between use of HPV vaccination and risky sexual
behaviors among African American women, ages 18–49?
H03: There is no association between use of HPV vaccination and risky sexual
behaviors among African American women, ages 18–49.
H03: There is an association between use of HPV vaccination and risky sexual
behaviors among African American women, ages 18–49.
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Threats to Validity
Cross-sectional study designs are limited in establishing causal relationships and
directionality (Frankfort-Nachmias & Nachmias, 2008). In addition, cross-sectional
study designs are used to describe the pattern of relationship between variables and as a
result, the elements of manipulation and control that are present in true experimental
designs are absent in these designs (Frankfort-Nachmias & Nachmias, 2008).
NHANES oversamples certain population subgroups in efforts to increase the
reliability and precision of health status indicator estimates for these groups (CDC, 2013).
Since this study involved the analysis of secondary data, there may be threats to content
and construct validity of this study. For example, internal validity was affected due to
missing data from variables, other unaccounted errors in the data collection itself, and
response and measurement bias. In addition, since data from 2013–2014 was studied,
there may have been a significant change in variables, participant responses, or other
factors that could have altered or skewed responses throughout the years analyzed.
Lastly, this study included a small sample size of African American women, which may
not be the representative of larger African American populations of women.
Ethical Procedures
This study did not have any direct contact with human subjects as it involved
analysis of secondary data collected from 2013 and 2014. In 2003, the NHANES
Institutional Review Board (IRB) changed its name to the NCHS Research Ethics Review
Board (ERB) (CDC, 2017b). The NCHS Research Ethics Review Board reviewed the
request for continuation of Protocol #2011- 17- NHANES Survey, which included 2013–
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2014 datasets and was approved (CDC, 2017b). In regards to the confidentiality of
participants, CDC ensured all human subjects that all data collected would be held in the
strictest confidence (CDC, 2017b). CDC also provided information to participants
regarding confidentiality of information relative to the Public Health Service Act (42
USC 242k) (authorizes collection) and Section 308(d) of that law (42 USC 242m), the
Privacy Act of 1974 (5 USC 552A), and the Confidential Information Protection and
Statistical Efficiency Act (PL 107-347) (CDC, 2017b). To ensure complete, safe, and
secure data, code numbers were assigned in place of names or other personal identifiers
(CDC, 2017b). Furthermore, ethical approval was sought and approved by the Walden
University Institutional Review Board (IRB Approval Number 06-09-17-0568615).
Dataset treatment post-analysis. Secondary NHANES data used in this study
were examined without full disclosure of personal information and identifiers in order to
avoid an ethical breach. Any breach in data or release of data would be resolved by
NHANES. All data utilized for this study was saved on a Lexar encrypted flash drive,
and will be properly deleted from the corresponding technological device after five (5)
years, in pursuant with Walden University IRB guidelines.
Summary
In summation, this section discussed the research design (cross-sectional,
quantitative), rationale and methodology of the study. The methodology section
described the study population (African American women ages 18–49 from the United
States noninstitutionalized population (NHANES 2013–2014), secondary data
management, sampling and sampling procedures, and instrumentation and
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operationalization of constructs. When describing the instrumentation and
operationalization of constructs, the dependent and independent variables, the data
collection and management techniques, and the data analysis plan were all described.
Additionally, this section discussed threats to validity, ethical considerations, and dataset
treatment post analysis. The next section, Section 3, presents the results and findings of
this study. This section also discusses the period for data collection, the actual
recruitment and the response rate of participants, and discrepancies in the use of the
secondary dataset. Descriptive and demographic characteristics of the sample, basic
univariate, and bivariate and multivariate analyses are also presented.
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Section 3: Presentation of the Results and Findings
Introduction
The purpose of this quantitative study was to explore the relationship between use
of HPV vaccination and personal history of HPV, reduced access to healthcare, and risky
sexual behaviors among African American women, ages 18–49, living in the United
States. Section 3 includes results of statistical analysis on data collected from NHANES.
In this section I provided a description of the timeframe and sample population
demographics, representativeness of the sample, and univariate characteristics and
analysis of the sample. The study results subsection includes the results of the chi-square
tests for RQ1, RQ2, and RQ3, and the multivariate logistic regression model.
Data Collection of Secondary Data Set
Each year, approximately 5,000 individuals of all ages are interviewed in their
homes and complete the health examination component of the survey, which is conducted
in a mobile examination center (MEC; CDC, 2017c). NHANES data files contain
information pertaining to demographics, diet, examination and laboratory history, and
questionnaires. As previously mentioned, I utilized 2013–2014 data as it pertained to
population characteristics (demographics), disease/infection-related results (laboratory),
and lifestyle behaviors (questionnaire) to conduct chi-square and logistic regression
analyses on HPV vaccination, as identified by the research questions of this study.
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Time Frame and Response Rates
According to NHANES, data proposals begin 2 years prior to the actual survey
time frame (see Appendix B for more information on content planning process and data
release schedule). Data proposals for 2013–2014 data files launched in 2011. A total of
5,172 women (unweighted sample size) were interviewed, which produced a 71.4%
response rate (please see Appendix C for more information on unweighted response rates
for NHANES 2013–2014). However, only 4,982 women (unweighted sample size) were
examined, producing a 68.8% response rate (please see Appendix C). For the purposes
of this study, only 229 African American women were studied. Due to the lack of
responses from African American women, many of the data variables were subject to
missing values. Although the sample used in this study (229 women) was smaller than
initially planned, adequate statistical power was achieved (>0.90) due to the high effect
size detected in the regression analysis (7.227, Table 12, G*Power Calculator) (Erdfelder,
Faul, & Buchner, 1996).
Descriptive Demographics of the Sample
The sample population was 229 African-American women. All 229 women
responded to questions regarding reduced access to healthcare and risky sexual behaviors.
All respondents were between the ages of 18–49, the average age being 32.50.
Representativeness of the Sample
According to the NHANES (CDC, 2017c), the sample for the survey is selected to
be representative of the United States population of all ages. In efforts to obtain
responses from samples that are representative of certain age groups and racial/ethnic
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groups, NHANES over-samples individuals 60 and older and African American and
Hispanic populations (CDC, 2017c). Of the 5,000 households selected for NHANES,
229 African American women ages 18–49 formed the study sample.
Study Results
Univariate Characteristics of the Sample
Nearly 60% of women included in this study were between the ages of 18 and 34.
Fifty-two percent (52.8%) of the women were never married. Nearly 40% (39.6%)
attended some college or obtained an associate’s degree, while 16.2% were college
graduates. All the women had an annual household income less than or equal to $39,999
(100%). Seventy-one percent (71.2%) of the women had health insurance coverage.
Nearly 90% of the women had a routine place to go for healthcare, and 87.3% had
received healthcare at least once over the past year. Eighty percent (80%) of women had
engaged in some form of risky sexual behavior. Eighty-six percent (86.4%) of women
stated they had never been told by a doctor they had HPV, while 83.3% had never
received the HPV vaccination.
In this section I displayed the study results for each research question. To
determine whether there was an association between use of HPV vaccination and
personal history of HPV, reduced access to healthcare, and risky sexual behaviors among
African American women ages 18–49, I conducted chi-square tests. Table 2 displays the
demographic and behavioral characteristics of the population. Table 3 displays the
distributions of and the chi-square results for population demographics and behavioral
characteristics by HPV vaccination. Table 4 displays the statistical cross-tabulation for
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HPV infection by HPV vaccination. Tables 5-7 display the statistical cross-tabulations
associated with reduced access to healthcare. Statistical cross-tabulations between risky
sexual behaviors and HPV vaccination are displayed in Tables 8-11. The logistic
regression of covariates by HPV vaccination is shown in Table 12. All the results are
discussed per research question and per table below.
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Table 2
Univariate Descriptive Analyses of Population Demographics and Behavioral
Characteristics
N = 229

n

Age
18–34
134
35–49
95
Marital status
Married
49
Widowed
2
Divorced
25
Separated
5
Never married
121
Living with partner
27
Educational attainment
Less than 9th grade
6
Grades 9–12
38
High school graduate/GED or
54
equivalent
Some college or Associate’s degree
88
College graduate or above
36
Annual household income
≤ $39,999
227
Health insurance coverage
Yes
163
No
66
Routine place to go for healthcare
Yes
205
No, there is no place to go
24
Number of times healthcare has been received in the
last year
0
29
1–3
154
≥4
46
Ever engaged in risky sexual behaviors
Yes
183
No
46
Ever been told by a doctor you had HPV
Positive
Negative
6
Ever received HPV vaccination
38
Yes
37
No
185
*Note: Those with missing information were excluded from percentages.

%

58.5
41.5
21.4
.9
10.9
2.2
52.8
11.8
2.8
17.1
24.3
39.6
16.2
100
71.2
28.8
89.5
10.5

12.7
67.2
20.1
80.0
20.0

13.6
86.4
16.7
83.3

46
Table 3
Distribution of Population Demographics and Behavioral Characteristics and Statistical
Cross-tabulations for them by HPV Vaccination
Received HPV Vaccination
N = 229

Yes
n

No
%

n

Chi-square
%

p-value

Age
18–34
35–49
Marital status
Married
Widowed
Divorced
Separated
Never married
Living with partner
Educational attainment
Less than 9th grade
Grades 9–12
High school graduate/GED or
equivalent
Some college or Associate’s
degree
College graduate or above
Annual household income
≤ $39,999
Health insurance coverage
Yes
No
Routine place to go for healthcare
Yes
No, there is no place to go
Number of times healthcare has been
received in the last year
0
1–3
≥4
Ever engaged in risky sexual behaviors
Yes
No
Ever been told by a doctor you had HPV
Yes
No

33
4

89.0
11.0

98
87

53.0
47.0

<.0001

4
0
3
1
27
2

10.8
0.0
8.1
2.7
73.0
5.4

44
2
22
4
91
22

23.7
1.0
12.0
2.2
49.1
12.0

.173

2
8
5

5.4
21.6
13.5

3
30
47

1.6
17
26.4

.102

19
3

51.4
8.1

66
32

37
18

37

100

183

100

NR

26
11

70.0
30.0

132
53

71.3
28.7

.895

33
4

89.2
10.8

165
20

89.2
10.8

1.00

4
21
12

11.0
57.0
32.0

24
129
32

13.0
70.0
17.0

.108

30
7

81.0
19.0

148
37

80.0
20.0

.880

0
10

0
100

5
28

15
85

.190
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RQ1: Is there an association between use of HPV vaccination and personal
history of HPV among African American women ages 18–49?
Nearly 12% (11.6%) of the women in the sample had a history of HPV. About
15% (15.2 %) of those who did not receive HPV vaccine had a history HPV. Having
HPV was not significantly associated with HPV vaccination among African American
women ages 18–49 in the United States (χ2=1.715, p=0.190), which is shown in Tables 3
and 4. As a result, there was not sufficient evidence to reject the claim that there is no
association between use of HPV vaccination and personal history of HPV among African
American women, ages 18–49. This implies that personal history of HPV among African
American women does not impact HPV vaccination.
Table 4
Statistical Cross-tabulation for HPV Infection by HPV Vaccination
Received HPV vaccine * Ever told by doctor you had HPV Cross-tabulation
Ever told by doctor you had HPV
Yes
Count
Yes

% within Received HPV
vaccine

Received HPV vaccine

Count
No

% within Received HPV
vaccine
Count

Total

% within Received HPV
vaccine

Total

No
0

10

10

0.0

100

100

5

28

33

15.2

84.8

100

5

38

43

11.6

88.4

100
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RQ2: Is there an association between use of HPV vaccination and reduced access to
healthcare among African American women ages 18–49?
About seventy one percent (71.2%) of women were covered by health insurance,
while 11.7% of those covered by health insurance received the HPV vaccine. Health
insurance coverage was not significantly associated with HPV vaccination among
African American women ages 18–49 in the United States (χ2=0.018, p=0.895), which is
shown in Tables 3 and 5. The results suggest that insurance status does not impact HPV
vaccination. Next, having a routine place to go for healthcare was not significantly
associated with HPV vaccination among African American women ages 18–49 in the
United States (χ2=0.000, p=1.000), which is shown in Tables 3 and 6. The results suggest
that having a routine place to go for healthcare does not impact HPV vaccination. About
89% (89.2%) of the patients had a routine place to go for healthcare, while 10.8% of
women had no routine place to go for healthcare. Lastly, receiving healthcare in the last
year was not significantly associated with HPV vaccination among African American
women ages 18–49 in the United States (χ2=0.018, p=4.45), which is shown in Tables
3and 7. More than 12% (12.6%) of women had not received any healthcare within the
last year, while 67.6% of women received healthcare 1–3 times last year. Due to the
findings, there is not sufficient evidence to reject the claim that there is no association
between use of HPV vaccination and reduced access to healthcare among African
American women ages 18–49 in the United States.
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Table 5
Statistical Cross-tabulation for Health Insurance Coverage by HPV Vaccination
Crosstab
Covered by health insurance?
Yes
Count
Yes

% within Received

Received HPV

HPV vaccine

vaccine

Count
No

% within Received
HPV vaccine
Count

Total

% within Received
HPV vaccine

Total

No

26

11

37

70.3%

29.7%

100.0%

132

53

185

71.4%

28.6%

100.0%

158

64

222

71.2%

28.8%

100.0%
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Table 6
Statistical Cross-tabulation for Routine Healthcare Place by HPV Vaccination
Crosstab
Routine place to go for healthcare
Yes

Total

There is no
place

Count
Yes

% within Received HPV

Received HPV

vaccine

vaccine

Count
No

% within Received HPV
vaccine
Count
% within Received HPV

Total

vaccine

33

4

37

89.2%

10.8%

100.0%

165

20

185

89.2%

10.8%

100.0%

198

24

222

89.2%

10.8%

100.0%
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Table 7
Statistical Cross-tabulation for Healthcare Received by HPV Vaccination

Crosstab
# of times healthcare received in last year

Count
Yes

% within Received HPV
vaccine

Total

≥4

0

1–3

4

21

12

37

10.8%

56.8%

32.4%

100.0%

24

129

32

185

13.0%

69.7%

17.3%

100.0%

28

150

44

222

12.6%

67.6%

19.8%

100.0%

Received HPV vaccine
Count
No

% within Received HPV
vaccine
Count

Total

% within Received HPV
vaccine

RQ3: Is there an association between use of HPV vaccination and risky
sexual behaviors among African American women, ages 18–49?
Engaging in risky sexual behavior was not significantly associated with HPV
vaccination among African American women ages 18–49 in the United States (χ2=0.023,
p=0.880), which is shown in Tables 3 and 8. The results suggest that engaging in risky
sexual behaviors does not impact HPV vaccination. To further describe data, analyses
were conducted on individual variables that make up risky sexual behaviors: condom use,
coitarche, and number of male sexual partners, and are shown in Tables 9-11. Condom
use was not significantly associated with HPV vaccination among African American
women ages 18–49 in the United States (χ2=0.284, p=0.868), which is shown in Tables 3
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and 9. These results suggest that having sex without the use of condom does not impact
HPV vaccination. Coitarche, which is shown in Tables 3 and 10, was not significantly
associated with HPV vaccination among African American women ages 18–49 in the
United States (χ2=0.985, p=0.611). These results suggest that the age at which a woman
has sex for the first time does not impact HPV vaccination. Lastly, number of male
sexual partners, which is shown in Tables 3 and 11, was not significantly associated with
HPV vaccination among African American women ages 18–49 in the United States
(χ2=1.433, p=0.489). Based on findings, there is not sufficient evidence to reject the
claim that there is no association between use of HPV vaccination and risky sexual
behavior among African American women ages 18–49.

Table 8
Statistical Cross-tabulation for Risky Sexual Behaviors by HPV Vaccination
Crosstab
Risky sexual behavior

Count
Yes % of Total
Received HPV vaccine

Count
No

% of Total
Count

Total

% of Total

Total

Yes

No

30

7

13.5%
148
66.6%
178
80.2%

37

3.1% 16.6%
37

185

16.7% 83.3%
44

222

19.8% 100%
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Table 9
Statistical Cross-tabulation for Condom Use by HPV Vaccination
Crosstab
Ever received HPV vaccine
Yes

Total

No

Count

3

11

14

4.7%

17.2%

21.9%

4

23

27

6.2%

35.9%

42.2%

4

19

23

6.2%

29.7%

35.9%

11

53

64

17.2%

82.8%

100.0%

Never
% of Total

# of times you had sex
without the use of a
condom within the past

Count
Inconsistent
% of Total

year

Count
Always
% of Total
Count

Total
% of Total

Table 10
Statistical Cross-tabulation for Coitarche by HPV Vaccination
Crosstab
Ever received HPV vaccine
Yes
Count

Total

No
1

9

10

1.2%

10.5%

11.6%

11

35

46

12.8%

40.7%

53.5%

6

24

30

7.0%

27.9%

34.9%

18

68

86

20.9%

79.1%

100.0%

13 or younger
% of Total
How old when you first
had sex

Count
14-17
% of Total
greater than or

Count

equal to 18

% of Total
Count

Total
% of Total
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Table 11
Statistical Cross-tabulation for Number of Male Sexual Partners by HPV Vaccination
Crosstab
Ever received HPV vaccine
Yes
Count

Total

No
4

19

23

7.7%

36.5%

44.2%

5

11

16

9.6%

21.2%

30.8%

2

11

13

3.8%

21.2%

25.0%

11

41

52

21.2%

78.8%

100.0%

1-5
% of Total
# of Male Sexual
Partners in Lifetime

Count
6-10
% of Total
Count
Greater than or Equal to 11
% of Total
Count

Total
% of Total

Logistic Regression
Table 12 displays the logistic regression of HPV vaccination by Covariates.
Variables controlled for were age, marital status, educational attainment, and income.
After adjustments, marital status, educational attainment, and income were not
statistically significant. However, age was statistically significant. Women between the
ages of 18 and 34 were 7.22 times as likely to receive the HPV vaccine as women aged
35–49 years (OR: 7.22; 95% CI: 2.36 – 22.13). Confidence intervals were relatively wide
possibly due to the small sample size of this study.
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Table 12
Logistic Regression of HPV Vaccination by Covariates
HPV Vaccination
N = 229

OR

95% CI

18–34
35–49

7.227
Ref

(2.360 – 22.133)
Ref

Marital Status
Married
Not Married

0.751
Ref

(0.228 – 2.474)
Ref

Ref
0.552
0.193

Ref
(0.070 – 4.350)
(0.023 – 1.596)

0.559
0.212

(0.078 – 3.989)
(0.022 – 2.028)

>999.999
Ref

(<.0001 – >999.999)
Ref

Age

Educational attainment
Less than 9th grade
Grades 9–12
High school graduate/GED or
equivalent
Some college or Associate’s degree
College graduate or above
Income
≤ $39,999
Greater than or equal to $39,999

Summary
In conclusion, there is no association between use of HPV vaccination and
personal history of HPV, reduced access to healthcare, and risky sexual behaviors among
African American women in the United States between the ages of 18 and 49. However,
there was a statistically significant association between age and receipt of HPV
vaccination with women aged 18–34 being more than seven times as likely as women
aged 35–49 to have received the vaccination (OR: 7.22; 95% CI: 2.36 – 22.13). Section 4
serves as an overview of the interpretations, limitations, recommendation, and
conclusions that are relevant to this doctoral study. A comparison of findings to relevant
literature is also provided in Section 4.
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Section 4: Application to Professional Practice and Implications for Social Change
Introduction
The purpose of this quantitative study was to explore the relationship between the
receipt of HPV vaccination for cervical cancer prevention and personal history of HPV,
reduced access to healthcare, and risky sexual behaviors in African American women
ages 18–49. Overall there was no association between receipt of HPV vaccination and
any of these variables. However, there was a statistically significant association between
receipt of HPV vaccination and age. This section includes an interpretation of the
findings, limitations of the study, recommendations for further study, and implications for
professional practice positive social change.
Interpretation of the Findings
The analyses of the NHANES data indicated no significant associations between
receipt of HPV vaccination and personal history of HPV, reduced access to healthcare,
risky sexual behaviors, and most of the covariates investigated (i.e. marital status,
educational attainment, and annual household income). In the following subsection, I
compared findings to the literature and discussed this study’s significant result, age.
Findings to Literature
Personal history of HPV. In 2015, Strohl et al. sought to study the knowledge of
HPV, cervical cancer, and HPV vaccination in African American women living in urban
Chicago. The authors concluded that knowledge of HPV, cervical cancer, and HPV
vaccination was low in this population. Laz, Rahman and Berenson (2012) conducted a
study to provide an update on HPV vaccine initiation among women between the ages of
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18 and 26. The results showed that 77.3% of the women were not vaccinated. Lastly,
Okafor, Hu and Cook (2015) sought to determine the association between racial/ethnic
status and uptake and completion of the HPV vaccine series in college women. This
study also found low initiation of the HPV vaccination among black women. While this
current study did not study explore knowledge of HPV, cervical cancer, and HPV
vaccination, it did show that women between the ages of 18 and 34 were 7.22 times as
likely to receive the HPV vaccine as women aged 35–49 years (OR: 7.22; 95% CI: 2.36 –
22.13)..
Reduced access to healthcare. Wong and Do (2012) used the 2007 Health
Information National Trends Survey (HINTS) to examine predictors of physician/patient
discussion regarding the HPV vaccine in women 18 and older. The authors found a
statistically significant association between lower income and education levels and a
lower likelihood of HPV vaccine awareness. The current study did not find a statistically
significant association between lower income and education level and a lower likelihood
of HPV vaccine awareness. Brown, Wilson, Boothe and Harris (2011) studied the
knowledge, attitudes, beliefs, and practices of ethnically diverse black women regarding
cervical cancer screening and found that reduced access to healthcare was a major barrier
to receiving the HPV vaccination. In the current study, 71% of women had health
insurance, nearly 90% of women had a routine place to go for healthcare, and 67% of
women had received healthcare 1–3 times in the last year. While reduced access to
healthcare was not statistically significant, these results show that women in this sample
do have access to healthcare and do see healthcare providers often. It could be further
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suggested that health is important to these women despite the health outcomes often
associated with this population compared to women of other racial/ethnic groups.
Dempsey, Cohn, Dalton and Ruffin (2011) evaluated characteristics associated with HPV
vaccine uptake among women between the ages of 19 and 26 seen in primary care,
university-based clinics. One major finding of this study was that young adults had
higher rates of being uninsured compared to other ages.
Risky sexual behaviors. Vázquez-Otero et al. (2016) examined whether HPV
vaccination was associated with inconsistent condom use among college students
between the ages of 18 and 26. The authors found no association between HPV
vaccination and inconsistent condom use during vaginal, anal, or oral sex (VázquezOtero et al., 2016). These findings were consistent with previous studies, which also
found no differences in the number of sex partners and frequency of condom use between
individuals who were vaccinated and those who were not (Ratanasiripong, 2014). In a
similar study, Mullins et al. (2016) sought to examine the association between risk
perceptions after receiving the HPV vaccine and risky sexual behaviors and STI
diagnosis over 30 months following vaccination. The authors found that while the
greater perceived need for safer sexual behaviors following vaccination was associated
with condom use, it was not associated with the number of sexual partners or STI
diagnosis (Mullins et al., 2016). Lastly, Mayhew et al. (2014) assessed whether
adolescent risk perceptions after the first vaccine dose predicted subsequent risky sexual
behaviors and found that receiving the HPV vaccine did not alter risky sexual behaviors
among adolescents. Similar to these studies, the current study found that engaging in
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risky sexual behaviors was not statistically associated with receiving the HPV
vaccination.
Age. Age was the only statistically significant factor in the current study.
Women between the ages of 18 and 34 were 7.22 times as likely to receive the HPV
vaccine compared to women aged 35–49 years (OR: 7.22; 95% CI: 2.36 – 22.13).
Several studies also showed that age was statistically significant, p < .05, regardless of
racial/ethnic group (Laz, Rahman, & Berenson, 2012; Okafor, Hu, & Cook, 2015; Wong
& Do, 2012). These studies also showed that women who were middle aged were less
likely to be aware of and knowledgeable of the HPV vaccine and had lower vaccine
intake and completion rates compared to women of younger age groups. However, when
stratified by race/ethnicity, black women were less likely to be aware of the HPV vaccine
and less likely to be vaccinated. These study results suggest that it is important that
young women be continuously targeted for HPV and cervical cancer prevention. This is
especially vital due to the fact that many study results showed that as women become
older, they are either less likely to be vaccinated, less likely to initiate and/or complete
the recommended vaccine series, or less likely to be knowledgeable regarding HPV,
cervical cancer, and the HPV vaccine (Okafor, Hu, & Cook, 2015; Strohl et al., 2015;
Laz, Rahman, & Berenson, 2012).
Limitations of the Study
As previously mentioned, in this study there was a lack of female African
American respondents, which is consistent with similar studies that had a small sample
size and much missing data (Brown, Wilson, Boothe, & Harris; Okafor, Hu, & Cook,
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2015; Strohl et al., 2015; Wong & Do, 2012). As a result of the small sample size, there
was only one significant variable, age, when regression analysis was conducted. Next,
personal history of HPV may not have been accurately captured due to self-reporting.
Furthermore, it would have been interesting to know how many African American
women died as a result of cervical cancer, and the rate at which African American
women receive all three recommended doses of the HPV vaccine and follow the Pap
smear guidelines but are still infected with HPV. However, NHANES does not currently
provide this information.
According to current studies, there may be a relationship between alcohol
consumption and persistent HPV (Schabath et al., 2014; Weiderpass et al., 2001).
However, the current study was not able to analyze this variable due to missing data.
Smoking is another factor linked to the potential development of HPV infection due to
the carcinogens found in cigarette smoke which are capable of affecting multiple body
organs, parts, and functions (Schmotzer, 2009; Menard, 2008). In fact, cigarette smoke
metabolites and carcinogens have been found in the cells that line the cervix among
women who smoke (Myatt, 2013). However, smoking was not included in the analysis of
the current study due to the large amount of missing data. Lastly, parity was not analyzed
in the current study due to the unavailability of this variable in NHANES (Opara & Zaidi,
2007). Parity has been shown to increase the risk of developing cancer following an HRHPV infection (Borna, Tabassum, Jahan, Munshi & Unnesa, 2015).
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Recommendations
Given the small sample size of the current study, there is a need to conduct an
additional study that would recruit larger African American female populations. It would
be also helpful to assess other racial/ethnic groups to better capture the disparities that
exist regarding use of HPV vaccination. There is also a great need to further explore
other health behaviors of African American women; especially because they are screened
for cervical cancer as much as or more than Caucasian women but still die sooner. As
previously mentioned, African American women who are vaccinated with Gardasil may
not be protected against HPV (Vidal et al., 2014). A recommendation to utilize the GeneEden-VIR antiviral treatment, which has been noted as a safe and effective treatment
against HPV in African American women, has been clinically proven to reduce HPV
symptoms (Polansky & Itzkovitz, 2013). More education to the public and to African
American women and clinical studies are needed to determine if this treatment is an
alternative to the HPV vaccines that currently do not protect African American women
from HPV infections.
Because age was the significant result in the current study with women aged 18–
34 much more likely to receive HPV vaccination than 35–49 year olds, it would be
beneficial for public health practitioners and physicians to conduct effective outreach to
African American women between the ages of 18 and 34. Not only are African
American women in this age range at risk for not receiving HPV vaccination, but they
have the ability to influence other social and personal groups to receive and complete
HPV vaccination. Lastly, it is extremely important that regardless of age, African
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American women continuously encourage one another to get vaccinated and be
compliant with screening recommendations for cervical cancer. Furthermore, it is
necessary for public health practitioners to conduct outreach that is targeted towards
African American women and to ensure that HPV and cervical cancer are discussed at
healthcare visits. These outreach and education efforts can assist with increased
knowledge and awareness of HPV and cervical cancer and the importance of still
receiving the HPV vaccine despite current conversations and new studies surrounding the
vaccine’s ineffectiveness in African American women (i.e. an African American woman
may feel that if the vaccine does not protect against the strains of HPV found in African
American women, there is no benefit in vaccine intake and/or completion.
While the current study did include analysis of covariates analyzed in other
studies, there were additional variables that could not be investigated. Alcohol
consumption, tobacco consumption, and parity were not studied and should be further
analyzed in future studies.
Implications for Professional Practice and Social Change
Bridging the gap between research, policy, and practice to improve public health
and quality of life, and ultimately to affect positive social change, is essential. Additional
research is needed to address why the current HPV vaccines are protective in certain
racial/ethnic groups and any biological, genetic make-up, or underlying factors that may
explain this anomaly. Furthermore, public health professionals and healthcare providers
are needed to assist with initiating conversations in the African American community
related to HPV and cervical cancer prevention. In terms of policy, there are currently
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three states that require the HPV vaccine as a school requirement (Schwartz & Easterling,
2015). According to researchers, when children are receiving their preadolescent
vaccines is a great opportunity for children to be administered the HPV vaccine. If there
were laws mandating that schools nationwide make it a requirement for all children to
receive the HPV vaccine, this could perhaps further educate parents and encourage them
to receive the vaccine.
The current study can contribute to positive social change within the community
and the public health profession. If age impacts vaccination knowledge and decisions, it
is important that women especially of certain age groups be educated. In fact, a study by
Watts et al. (2009) highlighted the significance of vaccine knowledge in a wide range of
age groups among women. The authors examined attitudes regarding HPV vaccination
in Latina and non-Latina women between the ages of 18 and 55 and found that the most
common barriers to receiving the HPV vaccine were inadequate knowledge about the
vaccine and the belief among mothers that their daughter did not have any risk factors for
HPV infection. As a result, that study highlighted the importance of building a
foundation of knowledge in individuals who are at-risk and to their caretakers and role
models (i.e. mothers, grandmothers, friends, aunts, health advocates, teachers, etc.) who
may provide the path to vaccination for all.
Given the prevalence of HPV infection and the cervical cancer mortality in the
African American community, this study raises critical concerns on the need for
improved education and outreach in this community. Future targeted public health
education interventions should include partnerships with trusted community
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organizations, such as schools, community-based clinics, churches, and businesses, to
help assist in developing tailored, culturally informed, and community-supported
messages.
Conclusion
The purpose of this quantitative study was to explore the relationship between the
use of HPV vaccination and personal history of HPV, reduced access to healthcare, and
risky sexual behaviors among African American women ages 18–49 in the United States.
While this study found that no associations existed overall, age was statistically
significant. Women between the ages of 18 and 34 were 7.22 times as likely to receive
the HPV vaccine compared to women aged 35–49 years (OR: 7.22; 95% CI: 2.36 –
22.13). Thus, women who are in late adolescence and early adulthood are more likely to
be vaccinated. Not only is it important that these groups be continuously targeted for
HPV and cervical cancer prevention, but it is important that these groups of women assist
in educating middle-aged women and mothers or caregivers of children to receive the
HPV vaccine as well.
It is important to continue researching this topic and make political and practical
recommendations to prevent cervical cancer among African American women. Given the
promising scientific, medical, and technological advances in the prevention and early
detection of cervical cancer in the United States, disparities in the use of these resources
is concerning and is a reflection of a number of inadequacies in the country’s health
system. Given the ability to largely eradicate cervical cancer, the blatant racial disparities
in prevalence and mortality rates are inexcusable and need to be addressed with urgency.
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Future studies that integrate health belief modeling and drivers of health behavior may be
of benefit on this issue, specifically in African American women. This will allow for a
better understanding of the health behaviors, knowledge, and other factors that are
placing African American women at the forefront of HPV infection and cervical cancer
mortality. Public health education programs and interventions that focus on improving
knowledge of HPV, cervical cancer, and HPV vaccination in adult African American
women are necessary as a step towards positive social change in our world.
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HNSCC – Head and Neck Squamous Cell Carcinoma
HPV – Human Papillomavirus
HR – High Risk
IARC – International Agency for Research on Cancer
IRB – Institutional Review Board
IV – Independent Variable
LR – Low Risk
OR – Odds Ratio
NCI – National Cancer Institute
NCHS – National Center for Health Statistics
NHANES – National Health and Nutrition Examination Survey
NHIS – National Health Interview Survey
NIH – National Institutes of Health
SCC – Squamous Cell Carcinoma
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